The trial is being sponsored by the UW Program for Advanced Cell Therapy (PACT) in partnership with the Department of Pediatrics, Division of Pediatric Hematology, Oncology and Bone Marrow Transplant.
The Food and Drug Administration-approved trial will use a form of transplant that replaces a patient’s bone marrow with alpha-beta T-cell depleted peripheral blood stem cells from closely matched unrelated donors or family members.
Read the full article at: https://www.med.wisc.edu/news-and-events/2021/may/uw-begins-new-clinical-trial-for-blood-diseases/